ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $1.06M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
20% less capital invested
Capital invested by funds: $1.32M → $1.06M (-$258K)
43% less funds holding
Funds holding: 7 → 4 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$198K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$165K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$4K |
| 5 |
Morgan Stanley
New York
|
-$14 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $370K | -$165K | -11,453 | -29% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $360K | +$113K | +7,838 | +39% |
|
|
3
Jane Street
New York
| $328K | +$198K | +13,767 | +116% |
|
|
4
Simplex Trading
Chicago,
Illinois
| – | -$6K | -358 | Closed |
|
|
CG
5
Cutler Group
San Francisco,
California
| – | -$4K | -263 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$5K | -260 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$14 | -1 | -11% |
|
ZBIO Hedge Fund Activity: Q3 2018 in Review
4 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) for Q3 2018, worth a combined $1.06M — down 20% from $1.32M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZBIO and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Jane Street, adding an estimated $198K. The largest seller was Virtu Financial, cutting an estimated $165K.
- 4 institutional investors held ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) as of Q3 2018, down from 7 in Q2 2018.
- Funds reported $1.06M of ProShares UltraPro Short NASDAQ Biotechnology stock for Q3 2018, down 20% quarter-over-quarter.
- 0 funds opened new ProShares UltraPro Short NASDAQ Biotechnology positions in Q3 2018 and 3 closed out, a net change of -3 holders.
- The largest ProShares UltraPro Short NASDAQ Biotechnology buyer in Q3 2018 was Jane Street, an estimated $198K added.
- The largest ProShares UltraPro Short NASDAQ Biotechnology seller in Q3 2018 was Virtu Financial, an estimated $165K sold.
Based on aggregated 13F filings for Q3 2018.